Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations

C Ebersolt, J Premonta, A Prochiantz, M Perez… - Brain research, 1983 - Elsevier
When tested under conditions reducing the endogenous production of adenosine (presence
of adenosine deaminase (ADA) 1.6 IU/ml; and deoxyadenosine triphosphate (d-ATP)), and …
被引用次数：101 相关文章

Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations

C Ebersolt, J Premont, A Prochiantz… - Brain …, 1983 - pubmed.ncbi.nlm.nih.gov
When tested under conditions reducing the endogenous production of adenosine (presence
of adenosine deaminase (ADA) 1.6 IU/ml; and deoxyadenosine triphosphate (d-ATP), and in …

[引用][C] INHIBITION OF BRAIN ADENYLATE CYCLASE BY A1 ADENOSINE RECEPTORS: PHARMACOLOGICAL CHARACTERISTICS AND LOCATIONS

C EBERSOLT, J PREMONT, A PROCHIANTZ… - 1983 - pascal-francis.inist.fr
INHIBITION OF BRAIN ADENYLATE CYCLASE BY A1 ADENOSINE RECEPTORS:
PHARMACOLOGICAL CHARACTERISTICS AND LOCATIONS CNRS Inist Pascal-Francis CNRS …

Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations.

C Ebersolt, J Premont, A Prochiantz, M Perez… - Brain …, 1983 - europepmc.org
When tested under conditions reducing the endogenous production of adenosine (presence
of adenosine deaminase (ADA) 1.6 IU/ml; and deoxyadenosine triphosphate (d-ATP), and in …